Status:
COMPLETED
Antegrade and Retrograde Dissection and Re-entry Approach for CTO
Lead Sponsor:
Xijing Hospital
Conditions:
Chronic Total Occlusion of Coronary Artery
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
BACKGROUND：Chronic total occlusion (CTO) angioplasty is one of the most challenging procedures remaining for the interventional operator. Today, with contemporary CTO negotiation available strategies ...
Detailed Description
METHODS 1. Trial overview and study population. ① This clinical trial is a prospective, exploratory, nonrandomized, multicenter trial evaluating the frequency of angiographic restenosis and clini...
Eligibility Criteria
Inclusion
- CTO time \>3months and CTO length \>20mm
Exclusion
- age \<18-years-old or \>85-years-old,
- left ventricular ejection fraction ≦30%,
- allergy to medications (antiplatelet drugs, heparin, metal alloys, or contrast agents),
- a planned surgery within 6 months of PCI or planned thrombolysis,
- pregnant,
- a life expectancy of \<6 months.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03769038
Start Date
December 1 2018
End Date
September 30 2022
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First affiliated hospital of fourth military medical university
Xi'an, Shaanxi, China, 710032